Showing 1-5 of 8 :
Using Real-World Data to Unlock Better Outcomes in IBD & NASH Patients

Gastrointestinal and metabolic disorders are highly prevalent and result in reduced quality of life for many patients. Treatments are aimed at reducing symptoms and preventing complications and progression. More research is needed to better understand natural history and progression, treatment effectiveness, and outcomes. Register here Linked real-world data (RWD) and machine learning (ML) applications provide[…]

Using Real-World Data to amplify disability scores in Multiple Sclerosis patients

THU, JUN 9, 2022 11:00 AM – 12:00 PM EDT Register >> Assessing clinical and functional status in Multiple Sclerosis (MS) using the Expanded Disability Status Scale (EDSS) is critical to inform treatment decisions and monitoring the progression of illness. Yet, EDSS scores are documented infrequently and inconsistently due to the time required to complete[…]

CNS & Behavioral Health: Using RWD to Accelerate Research & Improve Outcomes

Tue, Jun 22, 2021 2:00 PM – 3:00 PM EDT Register >> Nearly 20% of Americans are diagnosed with a mental health condition every year. Yet, more than half of those don’t receive a treatment for their condition. Globally, neurological disorders are one of the leading causes of disability and death with few if any[…]

RWD for R&D and Market Access in Autoimmune and Chronic Diseases

Thu. Nov. 19, 2020 1:00 PM – 2:00 PM Register From accelerating clinical trials and gaining regulatory approval to expanding access and understanding market needs, this webinar will cover the basics of what makes real-world data regulatory and research grade and how it can transform your R&D and market access programs for autoimmune and other[…]